Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of 4.33% is 28% below its 5-year average of 6.01%, near the low end of its 5-year range (4.33%–8.55%).
As of the fiscal period ended Wednesday, December 31, 2025. 7.48% below its 12-month average of 4.68%.
Annual fiscal-year return on assets; no daily interpolation.
RETURN ON ASSETS (ROA)
4.33%
RETURN ON ASSETS (ROA) AVG TTM
4.68%
RETURN ON ASSETS (ROA) AVG 3Y
5.89%
RETURN ON ASSETS (ROA) AVG 5Y
6.01%
RETURN ON ASSETS (ROA) AVG 10Y
5.65%
RETURN ON ASSETS (ROA) AVG 15Y
6.16%
RETURN ON ASSETS (ROA) AVG 20Y
6.54%
CURRENT VS TTM AVG
-7.48%
CURRENT VS 3Y AVG
-26.45%
CURRENT VS 5Y AVG
-27.97%
CURRENT VS 10Y AVG
-23.30%
CURRENT VS 15Y AVG
-29.68%
CURRENT VS 20Y AVG
-33.84%
SECTOR MEDIAN · HEALTHCARE
5.14%
median of 90 covered companies
CURRENT VS SECTOR MEDIAN
-15.76%
vs the sector median at left
Danaher Corporation
Market Cap
$143.23B
Return on Assets (ROA)
4.33%
TTM Avg
4.68%
3Y Avg
5.89%
5Y Avg
6.01%
Market Cap
$132.36B
Return on Assets (ROA)
16.06%
TTM Avg
6.37%
3Y Avg
11.74%
5Y Avg
14.58%
Market Cap
$131.94B
Return on Assets (ROA)
10.59%
TTM Avg
-0.92%
3Y Avg
3.28%
5Y Avg
1.99%
Market Cap
$124.38B
Return on Assets (ROA)
15.04%
TTM Avg
13.09%
3Y Avg
12.00%
5Y Avg
11.68%
Market Cap
$120.58B
Return on Assets (ROA)
1.93%
TTM Avg
1.25%
3Y Avg
1.93%
5Y Avg
2.38%
Market Cap
$118.72B
Return on Assets (ROA)
5.61%
TTM Avg
5.13%
3Y Avg
4.62%
5Y Avg
4.65%
Market Cap
$180.65B
Return on Assets (ROA)
-6.56%
TTM Avg
7.62%
3Y Avg
7.90%
5Y Avg
6.83%
Market Cap
$104.65B
Return on Assets (ROA)
5.20%
TTM Avg
5.08%
3Y Avg
5.08%
5Y Avg
2.52%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Danaher Corporation (DHR) | $143.23B | 4.33% | 4.68% | 5.89% | 6.01% |
| Vertex Pharmaceuticals Incorporated (VRTX)vs › | $132.36B | 16.06% | 6.37% | 11.74% | 14.58% |
| Bristol-Myers Squibb Company (BMY)vs › | $131.94B | 10.59% | -0.92% | 3.28% | 1.99% |
| Pfizer Inc. (PFE)vs › | $158.42B | 2.16% | 3.75% | 6.08% | 7.08% |
| Intuitive Surgical, Inc. (ISRG)vs › | $124.38B | 15.04% | 13.09% | 12.00% | 11.68% |
| CVS Health Corp. (CVS)vs › | $120.58B | 1.93% | 1.25% | 1.93% | 2.38% |
| Medtronic plc (MDT)vs › | $118.72B | 5.61% | 5.13% | 4.62% | 4.65% |
| Gilead Sciences, Inc. (GILD)vs › | $180.65B | -6.56% | 7.62% | 7.90% | 6.83% |
| McKesson Corporation (MCK)vs › | $104.65B | 5.20% | 5.08% | 5.08% | 2.52% |
| Stryker Corporation (SYK)vs › | $104.79B | 7.78% | 6.88% | 7.02% | 6.41% |
ROA
4.3%
ROE
7.6%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | 4.33% |
| 2024-12-31 | 5.03% |
| 2023-12-31 | 5.64% |
| 2022-12-31 | 8.55% |
| 2021-12-31 | 7.73% |
| 2020-12-31 | 4.79% |
| 2019-12-31 | 4.12% |
| 2018-12-31 | 5.54% |
| 2017-12-31 | 5.34% |
| 2016-12-31 | 5.64% |
| 2015-12-31 | 5.39% |
| 2014-12-31 | 7.02% |
| 2013-12-31 | 7.77% |
| 2012-12-31 | 6.98% |
| 2011-12-31 | 6.58% |
| 2010-12-31 | 8.07% |
| 2009-12-31 | 5.88% |
| 2008-12-31 | 7.53% |
| 2007-12-31 | 6.98% |
| 2006-12-31 | 8.72% |
| 2005-12-31 | 9.80% |
| 2004-12-31 | 8.78% |
| 2003-12-31 | 7.79% |
| 2002-12-31 | 4.82% |
| 2001-12-31 | 6.18% |
| 2000-12-31 | 8.04% |
| 1999-12-31 | 8.59% |
| 1998-12-31 | 6.68% |
| 1997-12-31 | 8.24% |
| 1996-12-31 | 11.77% |
